From left to right: Nermin Uvejzovik, Staci Beck, Aubrie Smith, Mitzi Irish, Carrie Pederson, and Derek Gleue accept their third place award in the annual Pipetting Challenge. Not pictured: Sheri Mitchell, Wendy Dong, Cindy Kuo, and Kris Moore. |
December 11, 2023 |
Seven ARUP Teams Finish in the Top 10 in National Pipetting Challenge More than 250 ARUP employees participated in Advanced Instruments’ Pipetting Challenge this year. Seven ARUP teams finished in the top 10 in the nationwide competition. |
Madhu Menon, MD, PhD, FCAP, ARUP’s section chief of Hematopathology, works with a team of experts to deliver accurate and timely results. |
December 7, 2023 | PhD scientists, analysts, and medical directors within ARUP’s Hematopathology department meet often to ensure clinicians and patients receive a diagnosis that reflects an integrated approach. |
The AAV5 DetectCDx™ Kit received its Conformitée Européene (CE) mark in January 2022, and testing is being performed by a Medicover facility in Germany. |
December 6, 2023 |
Partnership Between ARUP and Medicover Expands Access to Companion Diagnostic in the European Union ARUP and Medicover have partnered to provide a new companion diagnostic test to European Union patients. The test helps identify individuals eligible for a new gene therapy for severe hemophilia A. |
Utah Business magazine has honored ARUP Laboratories with a 2023 Best Companies to Work For Award. ARUP has earned this award every year since 2018. |
December 1, 2023 |
ARUP Laboratories Honored With 2023 Best Companies to Work For Award From Utah Business Magazine Utah Business magazine honored ARUP Laboratories with its Best Companies to Work For award for the sixth consecutive year based on anonymous employee survey results. |
Jonathan Genzen, MD, PhD (left), chief medical officer and senior director of governmental affairs, and Jonathan Carr, JD (right), compliance officer, prepare for ARUP’s webinar on the FDA’s proposed rule to regulate lab-developed tests. |
November 30, 2023 |
Watch Now: ARUP Experts Host Q&A Session on FDA’s Proposal to Regulate Lab-Developed Tests Days before the public comment period ends, ARUP Laboratories’ experts host webinar to educate and encourage attendees to provide comments on the FDA’s proposed rule to regulate lab-developed tests. |
ARUP Laboratories has released the company’s public comment in response to the FDA’s plan to regulate LDTs. |
November 29, 2023 |
ARUP Laboratories Urges FDA to Withdraw Proposed Rule Regulating Laboratory-Developed Tests ARUP believes the FDA’s plan to regulate lab-developed tests will limit access to testing, increase costs, and face a court challenge, and is calling for collaboration to better address LDT oversight. |